No front page content has been created yet.

Welcome to Regenix

 

Regenix Drugs Ltd incorporated as public ltd company (unlisted) in the year 2007. The Corporate office is located at Chennai. India 

Promoters 

The promoters are Dr A Ramamurthy and 2500 medical doctors. Dr A Ramamurthy is a post graduate in internal medicine, with gold medal from Madras University. The promoter has 25 years of health care experience as consultant and Director of BG hospital. Founder and Managing director of Grandix pharmaceutical company and Grandix Laboratories, which were sold to Strides Arco Labs in 2007 for 30 Million USD.

Vision 

To become a global pharmaceutical company 

Mission 

To invent or innovate newer medicines and change the outcome of health care positively. Also makes significant changes in the benefits of all stakeholders

Quality policy

We manufacture medicinal product with high degree of responsibility to provide 100 % quality product keeping in mind of safety and efficacy of our product to alleviate the sufferings of patients without fail

Business model

  • Pharmaceutical formulation manufacturing, marketing and exporting
  • Manufacturing and marketing of Biosimilars
  • Import and marketing of medical devices, diagnostic reagents and chromogenix assay kits for manufacturing of heparin groups
  • Retail pharmacy Chain
  • Diagnostic labs Chain
  • Medical disposables & First aid kit manufacturing and export

Read More ›


Acheivements

2018-19:

RDL – pharma division launched 12 new products in the field of Gynecology, Pediatrics and diabetology

The manufacturing facility at Alathur for small molecule is recertified for WHO GMP

The plant developed 26 products with Asian CTD dossier

Regenix super specialty lab chain [ NABL accredited] – developing HPV diagnostic kit

The RDL group work force is 850

Read More ›


Highlights

RDL subsidy Regenix Bioscience raised 50,000,000 INR to set up the Biosimilar facility

The Biosimilar fill finish facility is completed and waiting for Regulatory approval

Recombinant Human Insulin is waiting for Regulatory approval

Read More ›


Latest News

Regenix Annual Report 2019

RDL now exporting pharmaceutical finished goods to South America and Philippines

MOUs for Business collaborations

  1.  MOU with Julphar RAK – UAE
  2.  MOU with NCPC china
  3.  MOU with Biological Solutions USA

Read More ›